Abstract
Background:A humanized, anti-human IL-6 receptor monoclonal antibody, tocilizumab, was developed to block IL-6 signaling and has been used as an effective therapeutic agent for patients that do not respond to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have